GS
PROF

Gagnon Securities’s Profound Medical PROF Stock Holding History

Gagnon Securities’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
1,960,074
+15,750
+0.8% +$106K 2.51% 16
2026
Q1 		$12.6M Buy
1,944,324
+263
+0% +$1.82K 2.91% 13
2025
Q4 		$15.3M Buy
1,944,061
+211,021
+12% +$1.36M 3.12% 10
2025
Q3 		$8.47M Sell
1,733,040
-16,873
-1% -$86.1K 1.7% 22
2025
Q2 		$10.3M Buy
1,749,913
+52,233
+3% +$276K 2.1% 21
2025
Q1 		$9.88M Buy
1,697,680
+45,149
+3% +$312K 2.17% 19
2024
Q4 		$12.4M Buy
1,652,531
+185,284
+13% +$1.42M 2.5% 17
2024
Q3 		$11.7M Sell
1,467,247
-41,274
-3% -$373K 2.32% 15
2024
Q2 		$12.7M Sell
1,508,521
-20,516
-1% -$165K 2.85% 9
2024
Q1 		$13M Sell
1,529,037
-12,539
-0.8% -$105K 3.09% 10
2023
Q4 		$13.1M Sell
1,541,576
-40,590
-3% -$386K 3.14% 9
2023
Q3 		$16.1M Sell
1,582,166
-22,974
-1% -$238K 4.04% 6
2023
Q2 		$20.9M Sell
1,605,140
-115,424
-7% -$1.43M 4.34% 5
2023
Q1 		$16M Sell
1,720,564
-57,641
-3% -$667K 3.36% 9
2022
Q4 		$19.4M Buy
1,778,205
+11,350
+0.6% +$61.9K 4.28% 5
2022
Q3 		$7.13M Buy
1,766,855
+439,323
+33% +$2.97M 1.57% 26
2022
Q2 		$9.68M Buy
1,327,532
+3,197
+0.2% +$25.3K 2.03% 21
2022
Q1 		$11.9M Buy
1,324,335
+246,978
+23% +$2.38M 1.94% 20
2021
Q4 		$12.1M Buy
1,077,357
+110,821
+11% +$1.38M 1.81% 25
2021
Q3 		$14.2M Buy
966,536
+165,691
+21% +$2.52M 2.1% 20
2021
Q2 		$13.1M Buy
800,845
+22,955
+3% +$427K 1.86% 21
2021
Q1 		$15.7M Sell
777,890
-43,306
-5% -$1.04M 2.39% 14
2020
Q4 		$16.9M Buy
821,196
+41,663
+5% +$766K 2.69% 13
2020
Q3 		$13.8M Buy
779,533
+47,818
+7% +$760K 2.93% 12
2020
Q2 		$12.4M Sell
731,715
-36,211
-5% -$457K 3% 13
2020
Q1 		$7.48M Buy
767,926
+71,116
+10% +$922K 2.54% 15
2019
Q4 		$7.63M Buy
+696,810
New +$6.42M 1.67% 25

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $238M AUM 61.63% 1-Year Est. Return

Gagnon Securities's PROF Position: Q2 2026 in Review

Gagnon Securities increased its Profound Medical (PROF) stake by 0.81% in Q2 2026, buying an estimated $106K and bringing the position to 1,960,074 shares worth $13M. The position accounts for 2.51% of the portfolio, ranked #16.

Gagnon Securities first reported a position in PROF in Q4 2019 and has held it in 27 quarters since. The position peaked at $20.9M in Q2 2023. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Gagnon Securities held 1,960,074 shares of Profound Medical worth $13M as of Q2 2026.
  • Gagnon Securities bought 15,750 Profound Medical shares in Q2 2026, an estimated $106K.
  • Profound Medical made up 2.51% of Gagnon Securities's portfolio in Q2 2026, its #16 holding.
  • Gagnon Securities first reported a position in Profound Medical in Q4 2019 and has held it in 27 quarters since.
  • Gagnon Securities's Profound Medical position peaked at $20.9M in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.